CAN Clinical Research is dedicated to advancing innovative, patient-centered studies that improve outcomes in infectious diseases and beyond. As part of CAN Community Health, our research program focuses on expanding access to cutting-edge therapies for HIV, hepatitis C, sexually transmitted infections, and emerging health conditions affecting underserved populations.

With a strong commitment to scientific excellence, ethical conduct, and community engagement, our experienced team collaborates with leading pharmaceutical sponsors, academic institutions, and research partners to bring novel treatments and prevention strategies to the communities we serve. Through these collaborations with academic institutions, we help bridge clinical practice and scientific discovery, ensuring our patients benefit from the latest evidence-based advancements.

Through our integrated clinical and community-based approach, we strive to accelerate discovery while ensuring compassionate, high-quality care for every participant.